These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 33838320)
1. Autophagy in the diabetic heart: A potential pharmacotherapeutic target in diabetic cardiomyopathy. Dewanjee S; Vallamkondu J; Kalra RS; John A; Reddy PH; Kandimalla R Ageing Res Rev; 2021 Jul; 68():101338. PubMed ID: 33838320 [TBL] [Abstract][Full Text] [Related]
2. Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy. Li J; Xie Y; Zheng S; He H; Wang Z; Li X; Jiao S; Liu D; Yang F; Zhao H; Li P; Sun Y Biomed Pharmacother; 2024 Jun; 175():116790. PubMed ID: 38776677 [TBL] [Abstract][Full Text] [Related]
5. Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy. Kubli DA; Gustafsson ÅB Antioxid Redox Signal; 2015 Jun; 22(17):1527-44. PubMed ID: 25808102 [TBL] [Abstract][Full Text] [Related]
6. Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes. Kanamori H; Takemura G; Goto K; Tsujimoto A; Mikami A; Ogino A; Watanabe T; Morishita K; Okada H; Kawasaki M; Seishima M; Minatoguchi S Autophagy; 2015; 11(7):1146-60. PubMed ID: 26042865 [TBL] [Abstract][Full Text] [Related]
7. Helix B surface peptide attenuates diabetic cardiomyopathy via AMPK-dependent autophagy. Lin C; Zhang M; Zhang Y; Yang K; Hu J; Si R; Zhang G; Gao B; Li X; Xu C; Li C; Hao Q; Guo W Biochem Biophys Res Commun; 2017 Jan; 482(4):665-671. PubMed ID: 27865838 [TBL] [Abstract][Full Text] [Related]
8. Myocardial glycophagy flux dysregulation and glycogen accumulation characterize diabetic cardiomyopathy. Mellor KM; Varma U; Koutsifeli P; Daniels LJ; Benson VL; Annandale M; Li X; Nursalim Y; Janssens JV; Weeks KL; Powell KL; O'Brien TJ; Katare R; Ritchie RH; Bell JR; Gottlieb RA; Delbridge LMD J Mol Cell Cardiol; 2024 Apr; 189():83-89. PubMed ID: 38484473 [TBL] [Abstract][Full Text] [Related]
9. Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy. Zhang W; Xu W; Feng Y; Zhou X J Cell Mol Med; 2019 Sep; 23(9):5859-5867. PubMed ID: 31240820 [TBL] [Abstract][Full Text] [Related]
10. The interplay between autophagy and apoptosis in the diabetic heart. Ouyang C; You J; Xie Z J Mol Cell Cardiol; 2014 Jun; 71():71-80. PubMed ID: 24513079 [TBL] [Abstract][Full Text] [Related]
12. MiR-207 inhibits autophagy and promotes apoptosis of cardiomyocytes by directly targeting LAMP2 in type 2 diabetic cardiomyopathy. Xing R; Liu D; Cheng X; Tian X; Yan C; Han Y Biochem Biophys Res Commun; 2019 Nov; 520(1):27-34. PubMed ID: 31564413 [TBL] [Abstract][Full Text] [Related]
14. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. Zhang L; Ding WY; Wang ZH; Tang MX; Wang F; Li Y; Zhong M; Zhang Y; Zhang W J Transl Med; 2016 Apr; 14(1):109. PubMed ID: 27121077 [TBL] [Abstract][Full Text] [Related]
15. Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy. Tong M; Saito T; Zhai P; Oka SI; Mizushima W; Nakamura M; Ikeda S; Shirakabe A; Sadoshima J Circ Res; 2019 Apr; 124(9):1360-1371. PubMed ID: 30786833 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress. Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818 [TBL] [Abstract][Full Text] [Related]
17. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs. Packer M Cardiovasc Diabetol; 2020 May; 19(1):62. PubMed ID: 32404204 [TBL] [Abstract][Full Text] [Related]
18. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats. Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386 [TBL] [Abstract][Full Text] [Related]
19. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape. Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493 [TBL] [Abstract][Full Text] [Related]
20. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Yildirim SS; Akman D; Catalucci D; Turan B Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]